aprevo Transforaminal IBF
K-Number: K210542 · 2021-06-30
Device Summary
Frequently Asked Questions
What is the aprevo Transforaminal IBF?
aprevo Transforaminal IBF is a medical device that received FDA 510(k) clearance on 2021-06-30. The listed applicant is Carlsmed, Inc.. The 510(k) number is K210542.
When did aprevo Transforaminal IBF receive FDA 510(k) clearance?
aprevo Transforaminal IBF received FDA 510(k) clearance on 2021-06-30, under 510(k) number K210542.
Who is the listed applicant for aprevo Transforaminal IBF?
The FDA 510(k) record lists Carlsmed, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for aprevo Transforaminal IBF?
The FDA product code for aprevo Transforaminal IBF is MAX.
Other records listing Carlsmed, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: MAX)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.